Fifth Eye Inc. is an Ann Arbor, Michigan-based start-up that is developing clinical early warning systems based on physiologic waveforms to improve outcomes and reduce costs. Founded in 2017, Fifth Eye licensed technology from the University of Michigan, formed a team of experience healthcare entrepreneurs and leading-edge technologists, and is in the process of getting its first product cleared through the FDA for in-hospital use in detecting patient deterioration. The Analytic for Hemodynamic Instability product is a work in progress and is not yet available for sale.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/01/19 | $11,500,000 | Series A |
Arboretum Ventures Cultivation Capital InvestMichigan! MINTS | undisclosed |
